Latest analyst takes
Passive Income InvestingBULLLLY was added to BIGY as an option-writing candidate (weekly options available) because it also screened as sufficiently “productive” for covered call premium generation and diversification.4d agoPassive Income InvestingBULLI view Eli Lilly as a defensive/high‑quality pharmaceutical holding in the fund’s defensive layer due to its major pharma franchise.35d ago
Ale's World of StocksBULLEli Lilly (LLY) looks bullish to me after FDA approval of the oral GLP‑1 Zepbound—an easier-to-use pill expected to ship imminently at a low introductory price point—which should expand market access versus injectables.38d ago"LLY was added to BIGY as an option-writing candidate (weekly options available) because it also screened as sufficiently “productive” for covered call premium generation and diversification."
"I view Eli Lilly as a defensive/high‑quality pharmaceutical holding in the fund’s defensive layer due to its major pharma franchise."
"Eli Lilly (LLY) looks bullish to me after FDA approval of the oral GLP‑1 Zepbound—an easier-to-use pill expected to ship imminently at a low introductory price point—which should expand market access versus injectables."